NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00061984,Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma,https://clinicaltrials.gov/study/NCT00061984,,COMPLETED,"RATIONALE: Drugs used in chemotherapy such as doxorubicin and ifosfamide use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors, such as pegfilgrastim, cause the body to make blood cells. It is not yet known whether doxorubicin alone is more effective with or without ifosfamide and pegfilgrastim in treating soft tissue sarcoma.

PURPOSE: This randomized phase III trial is studying giving doxorubicin alone to see how well it works compared to giving doxorubicin together with ifosfamide and pegfilgrastim in treating patients with locally advanced or metastatic soft tissue sarcoma.",NO,Sarcoma,BIOLOGICAL: pegfilgrastim|DRUG: doxorubicin hydrochloride|DRUG: ifosfamide|PROCEDURE: multimodality therapy,Overall survival,Response as assessed by RECIST criteria|Toxicity as assessed by CTC 2.0|Treatment-related mortality,,European Organisation for Research and Treatment of Cancer - EORTC,,ALL,ADULT,PHASE3,455,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,EORTC-62012|EORTC-62012,2003-04,2010-05,2012-07,2003-06-06,,2014-10-27,"Karl-Franzens-University Graz, Graz, A-8010, Austria|Institut Jules Bordet, Brussels, 1000, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, B-2650, Belgium|U.Z. Gasthuisberg, Leuven, B-3000, Belgium|Tom Baker Cancer Centre - Calgary, Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute at University of Alberta, Edmonton, Alberta, T6G 1Z2, Canada|Doctor H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|McGill Cancer Centre at McGill University, Montreal, Quebec, H3G 1Y6, Canada|Aarhus Universitetshospital - Aarhus Sygehus, Aarhus, DK-8000, Denmark|Copenhagen County Herlev University Hospital, Copenhagen, DK-2730, Denmark|Institut Bergonie, Bordeaux, 33076, France|Centre Leon Berard, Lyon, 69373, France|CHU de la Timone, Marseille, 13385, France|Medizinische Universitaetsklinik I at the University of Cologne, Cologne, D-50924, Germany|Universitatsklinikum Carl Gustav Carus, Dresden, D-01307, Germany|Universitaetsklinikum Essen, Essen, D-45122, Germany|Medizinische Hochschule Hannover, Hannover, D-30625, Germany|Klinikum der Stadt Mannheim, Mannheim, D-68135, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, D-81377, Germany|Southwest German Cancer Center at Eberhard-Karls-University, Tuebingen, D-72076, Germany|Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, 1066 CX, Netherlands|University Medical Center Groningen, Groningen, 9700 RB, Netherlands|Leiden University Medical Center, Leiden, 2300 CA, Netherlands|Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, NL-6500 HB, Netherlands|University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam, 3000 CA, Netherlands|National Cancer Institute - Bratislava, Bratislava, 833 10, Slovakia|Vall d'Hebron University Hospital, Barcelona, 08035, Spain|Hospital Universitario San Carlos, Madrid, 28040, Spain|Centre Hospitalier Universitaire Vaudois, Lausanne, CH-1011, Switzerland|Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, B15 2TH, United Kingdom|Leeds Cancer Centre at St. James's University Hospital, Leeds, England, LS9 7TF, United Kingdom|Royal Marsden - London, London, England, SW3 6JJ, United Kingdom|University College of London Hospitals, London, England, WIT 3AA, United Kingdom|Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle-Upon-Tyne, England, NE4 6BE, United Kingdom|Derriford Hospital, Plymouth, England, PL6 8DH, United Kingdom|Cancer Research Centre at Weston Park Hospital, Sheffield, England, S1O 2SJ, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, AB25 2ZN, United Kingdom|Edinburgh Cancer Centre at Western General Hospital, Edinburgh, Scotland, EH4 2XU, United Kingdom|Western Infirmary, Glasgow, Scotland, G11 6NT, United Kingdom|Gartnavel General Hospital, Glasgow, Scotland, G12 0YN, United Kingdom",
